Q2 2017 Holdings
Filed 2017-08-14 | 16 holdings | $5.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cellectis(CLLS) | SPONDS ADR | 15117K103 | $2.6M | 100,000 | 47.9% |
| Aurinia Pharma(AUPH) | Common | 05156V102 | $1.5M | 252,129 | 28.8% |
| Adaptimmune(ADAPY) | SPONDS ADR | 00653A107 | $1.1M | 250,000 | 21.0% |
| Crispr(CRSP) | NAMEN AKT | H17182108 | $39.0K | 2,444,809 | 0.7% |
| Paratek | Common | 699374302 | $31.3K | 1,300,432 | 0.6% |
| Sientra | Common | 82621J105 | $21.3K | 2,199,012 | 0.4% |
| Cymabay(CBAYUSD) | Common | 23257D103 | $9.2K | 1,600,000 | 0.2% |
| Cascadian | Common | 14740B606 | $3.4K | 925,000 | 0.1% |
| Immune Design | Common | 45252L103 | $3.4K | 352,300 | 0.1% |
| Proteon | Common | 74371L109 | $3.0K | 2,017,872 | 0.1% |
| Chiasma(CHMA) | Common | 16706W102 | $2.9K | 2,080,595 | 0.1% |
| Dermira(DERMEUR) | Common | 24983L104 | $2.0K | 70,000 | 0.0% |
| Lombard Medical | Common | G55598109 | $1.8K | 3,473,452 | 0.0% |
| Histogenix | Common | 43358V109 | $1.6K | 888,889 | 0.0% |
| Innocoll | SPONDS ADR | 45780Q103 | $1.2K | 537,235 | 0.0% |
| Novan | Common | 66988N106 | $215 | 53,367 | 0.0% |